CA 125 half-life in ovarian cancer: a multivariate survival analysis.

Serum CA 125 regression after cytoreductive surgery and during the first three courses of chemotherapy was studied in 60 ovarian cancer patients and compared to known prognostic factors. Various methods reported in the literature to calculate a CA 125 half-live value were compared. Using two exponen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yedema, C. A., Kenemans, P., Voorhorst, F., Bon, G., Schijf, C., Beex, L., Verstraeten, A., Hilgers, J., Vermorken, J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968500/
https://www.ncbi.nlm.nih.gov/pubmed/8512822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968500/
https://www.ncbi.nlm.nih.gov/pubmed/8512822

Ejemplares similares